Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice

References

• Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75:373-6; PMID:17304869
   PubMed Web of Science ®Google Scholar
• Bock CT, Klingel K, Aberle S, Duechting A, Lupescu A, Lang F, Kandolf R. Human parvovirus B19: A new emerging pathogen of inflammatory cardiomyopathy. J Vet Med B Infect Dis Vet Public Health 2005; 52:340-3; PMID:16316397; http://dx.doi.org/10.1111/j.1439-0450.2005.00867.x
   PubMedGoogle Scholar
• Servant-Delmas A, Lefrére JJ, Morinet F, Pillet S. Advances in human B19 erythrovirus biology. J Virol 2010; 84:9658-65; PMID:20631151; http://dx.doi.org/10.1128/JVI.00684-10
   PubMed Web of Science ®Google Scholar
• Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A. Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol 2011; 49:3422-4; PMID:21734024; http://dx.doi.org/10.1128/JCM.00575-11
   PubMed Web of Science ®Google Scholar
• Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res 2014; 190:8-16; PMID:24998884; http://dx.doi.org/10.1016/j.virusres.2014.06.017
   PubMed Web of Science ®Google Scholar
• Ozawa K, Ayub J, Hao YS, Kurtzman G, Shimada T, Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 1987; 61:2395-406; PMID:3599180
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Roggendorf M, Deinhardt F. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods 1988; 20:155-68; PMID:2843558; http://dx.doi.org/10.1016/0166-0934(88)90149-8
   PubMed Web of Science ®Google Scholar
• Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84:1114-23; PMID:2551923; http://dx.doi.org/10.1172/JCI114274
   PubMed Web of Science ®Google Scholar
• Anderson S, Momoeda M, Kawase M, Kajigaya S, Young NS. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 1995; 206:626-32; PMID:7530397; http://dx.doi.org/10.1016/S0042-6822(95)80079-4
   PubMed Web of Science ®Google Scholar
• Zuffi E, Manaresi E, Gallinella G, Gentilomi GA, Venturoli S, Zerbini M, Musiani M. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. Viral Immunol 2001; 14:151-8; PMID:11398810; http://dx.doi.org/10.1089/088282401750234529
   PubMed Web of Science ®Google Scholar
• Filippone C, Zhi N, Wong S, Lu J, Kajigaya S, Gallinella G, Kakkola L, Söderlund-Venermo M, Young NS, Brown KE. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology 2008; 374:444-52; PMID:18252260; http://dx.doi.org/10.1016/j.virol.2008.01.002
   PubMed Web of Science ®Google Scholar
• Leisi R, Ruprecht N, Kempf C, Ros C. Parvovirus B19 Uptake Is a Highly Selective Process Controlled by VP1u, a Novel Determinant of Viral Tropism. J Virol 2013; 87:13161-7; PMID:24067971; http://dx.doi.org/10.1128/JVI.02548-13
   PubMed Web of Science ®Google Scholar
• Lu J, Zhi N, Wong S, Brown KE. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 2006; 193:582-90; PMID:16425138; http://dx.doi.org/10.1086/499599
   PubMed Web of Science ®Google Scholar
• Nie X, Zhang G, Xu D, Sun X, Li Z, Li X, Zhang X, He F, Li Y. The VP1-unique region of parvovirus B19 induces myocardial injury in mice. Scand J Infect Dis 2010; 42:121-8; PMID:19883162; http://dx.doi.org/10.3109/00365540903321580
   PubMed Web of Science ®Google Scholar
• Tzang BS, Tsai CC, Chiu CC, Shi JY, Hsu TC. Up-regulation of adhesion molecule expression and induction of TNF-α on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein. Clin Chim Acta 2008; 395:77-83; PMID:18538665; http://dx.doi.org/10.1016/j.cca.2008.05.012
   PubMed Web of Science ®Google Scholar
• Tsai CC, Tzang BS, Chiang SY, Hsu GJ, Hsu TC. Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. J Biomed Sci 2009; 16:14; PMID:19272186; http://dx.doi.org/10.1186/1423-0127-16-14
   PubMed Web of Science ®Google Scholar
• Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 2011; 48:1518-24; PMID:21555155; http://dx.doi.org/10.1016/j.molimm.2011.04.013
   PubMed Web of Science ®Google Scholar
• Tzang BS, Lee YJ, Yang TP, Tsay GJ, Shi JY, Tsai CC, Hsu TC. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Clin Chim Acta 2007; 382:31-6; PMID:17451664; http://dx.doi.org/10.1016/j.cca.2007.03.014
   PubMed Web of Science ®Google Scholar
• Chen DY, Tzang BS, Chen YM, Lan JL, Tsai CC, Hsu TC. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome. Clin Chim Acta 2010; 411:1084-9; PMID:20385113; http://dx.doi.org/10.1016/j.cca.2010.04.004
   PubMed Web of Science ®Google Scholar
• Kim BJ, Yoo KH, Li K, Kim MN. Parvovirus B19 infection associated with acute hepatitis in infant. Pediatr Infect Dis J 2009; 28:667; PMID:19561433; http://dx.doi.org/10.1097/INF.0b013e3181a645bd
   PubMed Web of Science ®Google Scholar
• Krygier DS, Steinbrecher UP, Petric M, Erb SR, Chung SW, Scudamore CH, Buczkowski AK, Yoshida EM. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol 2009; 15:4067-9; PMID:19705505; http://dx.doi.org/10.3748/wjg.15.4067
   PubMed Web of Science ®Google Scholar
• Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H, Krueger M, Fytili P, Schulz T, Cornberg M, et al. Intrahepatic longterm persistence of parvovirus B19 and its role in chronic viral hepatitis. J Med Virol 2009; 81:2079-88; PMID:19856479; http://dx.doi.org/10.1002/jmv.21638
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Jensen JMB, Hamilton-Dutoit S, Larsen CS. Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis 2010; 10:246; PMID:20727151; http://dx.doi.org/10.1186/1471-2334-10-246
   PubMed Web of Science ®Google Scholar
• Shcherbo D, Shemiakina II, Ryabova AV, Luker KE, Schmidt BT, Souslova EA, Gorodnicheva TV, Strukova L, Shidlovskiy KM, Britanova OV, et al. Near-infrared fluorescent proteins. Nat Methods 2010; 7:827-9; PMID:20818379; http://dx.doi.org/10.1038/nmeth.1501
   PubMed Web of Science ®Google Scholar
• Hsu TC, Tsai CC, Chiu CC, Hsu JD, Tzang BS. Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice. PLoS One 2013; 8:e68393; http://dx.doi.org/10.1371/journal.pone.0068393
   PubMed Web of Science ®Google Scholar
• Bihari C, Rastogi A, Saxena P, Rangegowda D, Chowdhury A, Gupta N, Sarin SK. Parvovirus B19 associated hepatitis. Hepat Res Treat 2013; 2013:472027; PMID:24232179
   PubMedGoogle Scholar
• Mihály I, Trethon A, Arányi Z, Lukács A, Kolozsi T, Prinz G, Marosi A, Lovas N, Dobner IS, Prinz G, et al. Observations on human parvovirus B19 infection diagnosed in 2011. Orvosi Hetilap 2012; 153:1948-57; http://dx.doi.org/10.1556/OH.2012.29447
   PubMedGoogle Scholar
• Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995; 172:1198-205; PMID:7594654; http://dx.doi.org/10.1093/infdis/172.5.1198
   PubMed Web of Science ®Google Scholar
• Rauff B, Idrees M, Shah SA, Butt S, Butt AM, Ali L, Hussain A, Irshad-Ur-Rehman, Ali M. Hepatitis associated aplastic anemia: a review. Virol J 2011; 8:87; PMID:21352606; http://dx.doi.org/10.1186/1743-422X-8-87
   PubMed Web of Science ®Google Scholar
• Tzang BS, Chiu CC, Tsai CC, Lee YJ, Lu IJ, Shi JY, Hsu TC. Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci 2009; 16:13; PMID:19272185; http://dx.doi.org/10.1186/1423-0127-16-13
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28:445-89; http://dx.doi.org/10.1146/annurev-immunol-030409-101212
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Larkin Iii J. Therapeutic targeting of STAT pathways in CNS autoimmune diseases. JAKSTAT 2013; 2:e24134; PMID:24058800
   PubMedGoogle Scholar
• Liu X, Lee YS, Yu CR, Egwuagu CE. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J Immunol 2008; 180:6070-6; PMID:18424728; http://dx.doi.org/10.4049/jimmunol.180.9.6070
   PubMed Web of Science ®Google Scholar
• Lee SY, Yoon BY, Kim JI, Heo YM, Woo YJ, Park SH, Kim HY, Kim SI, Cho ML. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Immunology 2014; 141:353-61; PMID:24708416; http://dx.doi.org/10.1111/imm.12196
   PubMed Web of Science ®Google Scholar
• Karonitsch T, Feierl E, Steiner CW, Karonitsch T, Feierl E, Steiner CW. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum 2009; 60:1463-71; PMID:19404947; http://dx.doi.org/10.1002/art.24449
   PubMed Web of Science ®Google Scholar
• Liang Y, Xu WD, Yang XK, Fang XY, Liu YY, Ni J, Qiu LJ, Hui P, Cen H, Leng RX, et al. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus. Autoimmunity 2014; 47:141-5; PMID:24437638; http://dx.doi.org/10.3109/08916934.2013.873415
   PubMed Web of Science ®Google Scholar
• Battle TE, Frank DA. The role of STATs in apoptosis. Curr Mol Med 2002; 2:381-92; PMID:12108949; http://dx.doi.org/10.2174/1566524023362456
   PubMedGoogle Scholar
• Hückel M, Schurigt U, Wagner AH, Stöckigt R, Petrow PK, Thoss K, Gajda M, Henzgen S, Hecker M, Bräuer R. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther 2006; 8:R17; http://dx.doi.org/10.1186/ar1869
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Tsutsui H, Xinshou O, Tokumoto M, Watanabe D, Shima Y, Yoshimoto T, Hirakata H, Kawase I, Nakanishi K, et al. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 2004; 16:303-14; PMID:14734616; http://dx.doi.org/10.1093/intimm/dxh030
   PubMed Web of Science ®Google Scholar
• Klinman DM, Tross D, Klaschik S, Shirota H, Sato T. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann NY Acad Sci 2009; 1175:80-8; PMID:19796080; http://dx.doi.org/10.1111/j.1749-6632.2009.04970.x
   PubMed Web of Science ®Google Scholar
• Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majó-Masferrer J, Labrador-Horrillo M, Vilardell-Tarrés M. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus 2007; 16:483-8; PMID:17670846; http://dx.doi.org/10.1177/0961203307079618
   PubMed Web of Science ®Google Scholar
• Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 2007; 56:1579-88; PMID:17469140; http://dx.doi.org/10.1002/art.22578
   PubMed Web of Science ®Google Scholar
• Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009; 31:539-50; PMID:19833085; http://dx.doi.org/10.1016/j.immuni.2009.09.002
   PubMed Web of Science ®Google Scholar